| Literature DB >> 23450643 |
Jennifer S Chang1, Fred Winston.
Abstract
Spt10 is a putative acetyltransferase of Saccharomyces cerevisiae that directly activates the transcription of histone genes. Deletion of SPT10 causes a severe slow growth phenotype, showing that Spt10 is critical for normal cell division. To gain insight into the function of Spt10, we identified mutations that impair or improve the growth of spt10 null (spt10Δ) mutants. Mutations that cause lethality in combination with spt10Δ include particular components of the SAGA complex as well as asf1Δ and hir1Δ. Partial suppressors of the spt10Δ growth defect include mutations that perturb cell-cycle progression through the G1/S transition, S phase, and G2/M. Consistent with these results, slowing of cell-cycle progression by treatment with hydroxyurea or growth on medium containing glycerol as the carbon source also partially suppresses the spt10Δ slow-growth defect. In addition, mutations that impair the Lsm1-7-Pat1 complex, which regulates decapping of polyadenylated mRNAs, also partially suppress the spt10Δ growth defect. Interestingly, suppression of the spt10Δ growth defect is not accompanied by a restoration of normal histone mRNA levels. These findings suggest that Spt10 has multiple roles during cell division.Entities:
Keywords: Spt10; Spt21; histones; suppressors
Mesh:
Substances:
Year: 2013 PMID: 23450643 PMCID: PMC3583463 DOI: 10.1534/g3.112.005389
Source DB: PubMed Journal: G3 (Bethesda) ISSN: 2160-1836 Impact factor: 3.154
S. cerevisiae strains used in this study
| Name | Genotype |
|---|---|
| FY2191 | |
| FY2915 | |
| FY2916 | |
| FY2917 | |
| FY2918 | |
| FY2919 | |
| FY2920 | |
| FY2921 | |
| FY2922 | |
| FY2923 | |
| FY2200 | |
| FY2924 | |
| FY2925 | |
| FY2926 | |
| FY2927 | |
| FY2928 | |
| FY2482 | |
| FY2929 | |
| FY2930 | |
| FY2931 | |
| FY2932 | |
| FY2933 | |
| FY2934 | |
| FY2935 | |
| FY2936 | |
| FY2937 | |
| FY2938 | |
| FY2939 | |
| FY2940 | |
| FY2941 | |
| FY2942 | |
| FY2943 | |
| FY2944 | |
| FY2945 | |
| FY2946 | |
| FY2947 | |
| FY2948 | |
| FY2949 | |
| FY1856 | |
| FY2950 | |
| FY2951 | |
| FY2952 | |
| FY2953 | |
| FY2954 | |
| FY2955 | |
| FY2956 | |
| FY2957 | |
| FY2958 | |
| FY2959 | |
| FY2960 | |
| FY2961 | |
| FY2962 | |
| FY2963 | |
| FY2964 | |
| FY2965 | |
| FY2966 | |
| FY2967 | |
| FY2816 | |
| FY2817 | |
| FY2968 | |
| FY2969 | |
| FY2970 | |
| FY2971 | |
| FY2972 | |
| FY1924 | |
| FY2973 | |
| FY2974 | |
| FY2975 | |
| FY2978 | |
| FY2979 | |
| FY2980 | |
| FY2981 | |
| FY2982 | |
| FY2903 | |
| FY2933 | |
| FY1235 |
Figure 2 Representative suppressors of the spt10Δ slow growth phenotype. Shown are fivefold dilution spot tests. spt10Δ strains were cured of the pFW217 SPT10-URA3-CEN plasmid and grown as described in Materials and Methods, then resuspended to 4 × 106 cells/mL. They were subjected to fivefold dilutions, spotted onto YPD medium, and photographed after 2 d. Strains were wild type (FY2200), spt21Δ (FY2482), (hta2-htb2)Δ hhf2Δ (FY2929), spt10Δ (FY2924), hsl7Δ spt10Δ (FY2930), nap1Δ spt10Δ (FY2931), bck2Δ spt10Δ (FY2932), lsm1Δ spt10Δ (FY2933), hsl7Δ (FY2934), nap1Δ (FY2935), bck2Δ (FY2936), lsm1Δ (FY2937), spt10Δ (FY2938), hsl7Δ nap1Δ spt10Δ (FY2939), hsl7Δ bck2Δ spt10Δ (FY2940), hsl7Δ lsm1Δ spt10Δ (FY2941), nap1Δ bck2Δ spt10Δ (FY2942), nap1Δ lsm1Δ spt10Δ (FY2943), bck2Δ lsm1Δ spt10Δ (FY2944), hsl7Δ nap1Δ bck2Δ spt10Δ (FY2945), hsl7Δ nap1Δ lsm1Δ spt10Δ (FY2946), hsl7Δ bck2Δ lsm1Δ spt10Δ (FY2947), nap1Δ bck2Δ lsm1Δ spt10Δ (FY2948), and hsl7Δ nap1Δ bck2Δ lsm1Δ spt10Δ (FY2949).
Figure 1 Mutations in genes encoding SAGA subunits lead to lethality or poor growth in an spt10Δ background. Shown are fivefold dilution spot tests. All strains were grown to saturation in SC-Ura medium in the presence of the pFW217 SPT10-URA3-CEN plasmid. They were serially diluted fivefold and spotted onto SC-Ura and 5-FOA plates to select for cells that have maintained or lost the SPT10 plasmid, respectively. The SC-Ura plate is shown after 2 d of incubation at 30° and the 5-FOA plate after 5 d. Upper and lower panels are from the same plate. The strains were wild type (FY2200), spt10Δ (FY2924), spt8Δ spt10Δ (FY2925) spt20Δ spt10Δ (FY2926), gcn5Δ spt10Δ (FY2927), and ubp8Δ spt10Δ (FY2928).
Figure 3 Perturbed progression through the bud morphogenesis checkpoint can suppress the spt10Δ growth defect. (A) Diagram of the Hsl−Swe1−Cdc28 pathway. (B, C) Fivefold dilution spot tests. Each strain was grown to saturation and diluted to 1.0 × 107 cells/mL for the densest spot. Strains in (B) were wild type (FY2200), spt10Δ (FY2924), hsl7Δ spt10Δ (FY2930), hsl1Δ spt10Δ (FY2951), mih1Δ spt10Δ (FY2952), swe1Δ spt10Δ (FY2953), hsl7Δ swe1Δ spt10Δ (FY2954), hsl7Δ (FY2934), hsl1Δ (FY2955), mih1Δ (FY2956), and swe1Δ (FY2957). Strains in (C) were wild type (FY2200), hsl7Δ (FY2934), cdc28-T18A Y19F (FY2958), spt10Δ (FY2924), hsl7Δ spt10Δ (FY2930), cdc28-T18A Y19F spt10Δ (FY2959), hsl7Δ cdc28-T18A Y19F spt10Δ (FY2960), and hsl7Δ cdc28-T18A Y19F (FY2961). Pictures were taken after 2 d.
Figure 6 Nongenetic means of suppressing the spt10Δ slow growth phenotype. (A) Fivefold dilutions were made as in Figure 3, then spotted onto YPD medium or YPD + 25 mM HU. Pictures were taken after 2 d. Strains were WT (FY2200), spt10Δ (FY2924), and mec1Δ sml1Δ (FY2967). mec1Δ sml1Δ mutants are hypersensitive to HU. (B) Wild-type (FY2200) and spt10∆ (FY2924) strains were subjected to fivefold serial dilutions as in Figure 3 and grown on YPD medium for two days or on YP + 3% glycerol medium for 5 d.
Primers used to measure histone mRNA levels
| Primer | Gene | Orientation | Sequence |
|---|---|---|---|
| FO6006 | Forward | TTCAAAACAAACAAATTTCA | |
| FO6007 | Reverse | AAATACCAGAACCGATCTTA | |
| FO6008 | Forward | GGAAAGTACAGAACAAGAGC | |
| FO6009 | Reverse | CTTTGTTTCTTTTCAACTCAG | |
| FO6010 | Forward | CAAACCACAAATAAACCATAC | |
| FO6011 | Reverse | AGGAAGTGATTTCATTATGC | |
| FO6012 | Forward | ACCAACAACAACTTACTCTACA | |
| FO6013 | Reverse | AATCACAATACCTAGTGAGTGA | |
| FO6014 | Forward | TATATAAACGCAAACAATGG | |
| FO6015 | Reverse | AACTGATGACAATCAACAAA | |
| FO6016 | Forward | TACTAAAGGATCCAAGCAAA | |
| FO6017 | Reverse | AAAAATTCCCGCTTTATATT | |
| FO6018 | Forward | AACAAACAAAAACAAGCAAC | |
| FO6019 | Reverse | TTGTTGTTACCGTTTTCTTA | |
| FO6020 | Forward | GTAGCAAAAACAACAATCAA | |
| FO6021 | Reverse | ATAATTTCAAACACCGATTG | |
| FO6145 | Forward | TTTTGTCCTTGTACTCTTCC | |
| FO6146 | Reverse | CTGAATCTTTCGTTACCAAT |
Genes identified by a transposon screen
| Gene | Effect When Combined With | Insertion Location Relative to ATG | Description |
|---|---|---|---|
| Improved growth | +1232 | Arginine N-methyltransferase involved in regulation of Swe1 degradation | |
| Improved growth | +1654 | Arginine N-methyltransferase involved in regulation of Swe1 degradation | |
| Improved growth | −191 | Part of a complex involved in degradation of cytoplasmic mRNAs | |
| Lethality | +102 | Histone chaperone | |
| Lethality | +283 | Histone chaperone | |
| Lethality | +530 | Unknown function | |
| Lethality | +1475 | Ser/Thr kinase; exit from mitosis | |
| Lethality | +361 | Component of U2 snRNP |
Genes found by SGA analysis whose deletion causes double-mutant lethality or extreme sickness with spt10Δ
| Gene | Description |
|---|---|
| MAP KKK in the protein kinase C signaling pathway | |
| Protein involved in bud site selection | |
| Component of chromatin assembly complex CAF-I | |
| Component of the COMA complex | |
| Cysteine biosynthesis | |
| Ubiquitin-mediated protein degradation | |
| Component of the Elongator complex | |
| Component of the Elongator complex | |
| Component of the Elongator complex | |
| Histone H4 | |
| Histone H3 | |
| Component of the HIR complex | |
| Component of the HIR complex | |
| Function unknown | |
| Component of the HIR complex | |
| Associates with the INO80 chromatin remodeling complex | |
| Binds DNA containing intrastrand cross-links formed by cisplatin | |
| Component of the COMA complex | |
| Component of the NatB N-terminal acetyltransferase | |
| Mitochondrial ribosomal protein of the large component | |
| Mitochondrial aspartyl-tRNA synthetase | |
| Endosomal Na+/H+ exchanger | |
| Facilitates vesicle-mediated vacuolar protein sorting | |
| Component of the mediator complex | |
| Negative regulation of glucose-repressible genes | |
| Cytosolic protein required for sporulation | |
| Component of the mitochondrial SAM complex | |
| Component of the SAGA complex | |
| Component of the SAGA complex | |
| Component of the Rpd3-Sin3 complex | |
| Component of the Slx5-Slx8 SUMO-targeted ubiquitin ligase complex | |
| Cytosolic copper-zinc superoxide dismutase | |
| Component of the SAGA complex | |
| Component of the SAGA complex | |
| Component of the SWR1 complex | |
| Component of TFIID, TFIIF, INO80, SWI/SNF, and NuA3 complexes | |
| Threonine synthesis | |
| Threonine synthase | |
| Chaperone required for maturation of the 20S proteasome | |
| Component of the peripheral membrane domain of the vacuolar H+-ATPase | |
| Protein degradation and quality control | |
| Component of the GARP complex | |
| Component of both the NuA4 histone H4 and SWR1 complexes | |
| Dubious open reading frame, overlaps |
Genes found by SGA analysis whose deletion suppresses the spt10Δ poor growth phenotype
| Gene | Description |
|---|---|
| Protein kinase C signaling pathway and the G1/S transition | |
| B-type cyclin involved in G2 to M progression | |
| Putative protein kinase | |
| Component of a class II histone deacetylase complex | |
| Component of the INO80 complex | |
| Myo-inositol transporter | |
| Synthesis of the glycosylphosphatidylinositol (GPI) core structure | |
| Part of complexes involved in RNA processing, splicing, and decay | |
| Part of complexes involved in RNA processing, splicing, and decay | |
| Bud morphogenesis, microtubule dynamics, and transport of histones H2A and H2B | |
| Component of the Set3C complex | |
| Component of the EGO complex | |
| Protein of unknown function, influences nuclear pore distribution |
spt10Δ is inviable with hir1Δ and asf1Δ
| Double Mutant | Phenotype |
|---|---|
| Inviable | |
| Inviable | |
| Viable | |
| Viable | |
| Viable | |
| Viable |
The phenotype was determined by testing the ability of the double mutant to survive loss of plasmid pFW217 (SPT10-URA3-CEN) by assaying growth on 5FOA plates as described in Materials and Methods. The cross done for each combination is listed below.
FY2978 × FY1235.
FY2924 × FY2979.
FY2903 × FY2938.
FY2980 × FY2933.
FY2981 × FY2982.
FY2903 x FY2933.
Figure 4 A mutation perturbing the G1/S transition can partially suppress the spt10Δ growth defect. Fivefold dilution spot assays were performed as in Figure 3. Strains were wild type (FY2200), cln3Δ (FY2962), spt10Δ (FY2924), and cln3Δ spt10Δ (FY2963). Pictures were taken after 2 d.
Figure 5 Suppression of the spt10Δ growth defect by mutations in the Lsm1-7-Pat1 complex. Dilution spot assays were performed as in Figure 3 with the following strains: wild type (FY2200), spt10Δ (FY2924), lsm1Δ spt10Δ (FY2933), pat1Δ spt10Δ (FY2964), lsm1Δ pat1Δ spt10Δ (FY2965), lsm1Δ (FY2937), and pat1Δ (FY2966). Pictures were taken after 2 d.
Figure 7 mRNA abundance for the core histone genes in growth suppressor strains. RNA was isolated and reverse transcribed, and real-time PCR with gene-specific primers (Table 2) was used to quantitate histone mRNA levels for (A) HTA1 and HTA2; (B) HTB1 and HTB2; (C) HHT1 and HHT2; and (D) HHF1 and HHF2. All values were normalized to ACT1 mRNA levels and are shown relative to wild type, which was assigned a value of 1. Shown is the mean ± SEM for at least three independent experiments. Strains were wild type (FY2200 and FY1856), spt10Δ (FY2924 and FY2938), spt21Δ (FY2816 and FY2817), hsl7Δ spt10Δ (FY2930 and FY2950), nap1Δ spt10Δ (FY2931 and FY2968), bck2Δ spt10Δ (FY2932 and FY2969), lsm1Δ spt10Δ (FY2933 and FY2970), hsl7Δ lsm1Δ spt10Δ (FY2941 and FY2971), bck2Δ lsm1Δ spt10Δ (FY2944), hsl7Δ nap1Δ bck2Δ lsm1Δ spt10Δ (FY2949 and FY2972), hsl7Δ (FY2934 and FY1924), nap1Δ (FY2935, FY2973), bck2Δ (FY2936, FY2974), and lsm1Δ (FY2937, FY2975).